These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Evaluation of troponin T criteria for periprocedural myocardial infarction in patients with acute coronary syndromes. Shugman IM; Diu P; Gohil J; Kadappu KK; Leung M; Lo S; Leung DY; Hopkins AP; Juergens CP; French JK Am J Cardiol; 2011 Mar; 107(6):863-70. PubMed ID: 21376928 [TBL] [Abstract][Full Text] [Related]
23. Rosuvastatin-induced high-density lipoprotein changes in patients who underwent percutaneous coronary intervention for non-ST-segment elevation acute coronary syndrome. Yun KH; Shin SN; Ko JS; Rhee SJ; Kim NH; Oh SK; Jeong JW J Cardiol; 2012 Nov; 60(5):383-8. PubMed ID: 22884684 [TBL] [Abstract][Full Text] [Related]
24. Evidence for a beneficial effect of glucose-insulin-potassium in patients with acute coronary syndromes: Did the IMMEDIATE trial solve an unanswered question? Mellbin L; Rydén L Expert Rev Cardiovasc Ther; 2012 Sep; 10(9):1097-9. PubMed ID: 23098145 [TBL] [Abstract][Full Text] [Related]
26. High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation. Holy EW; Besler C; Reiner MF; Camici GG; Manz J; Beer JH; Lüscher TF; Landmesser U; Tanner FC Thromb Haemost; 2014 Nov; 112(5):1024-35. PubMed ID: 25056722 [TBL] [Abstract][Full Text] [Related]
27. Endotoxin levels are associated with high-density lipoprotein, triglycerides, and troponin in patients with acute coronary syndrome and angina: possible contributions from periodontal sources. Goteiner D; Craig RG; Ashmen R; Janal MN; Eskin B; Lehrman N J Periodontol; 2008 Dec; 79(12):2331-9. PubMed ID: 19053924 [TBL] [Abstract][Full Text] [Related]
28. GGT levels in type II diabetic patients with acute coronary syndrome (does diabetes have any effect on GGT levels in acute coronary syndrome?). Emiroglu MY; Esen OB; Bulut M; Karapinar H; Kaya Z; Akcakoyun M; Kargin R; Aung SM; Alizade E; Pala S; Esen AM Acta Diabetol; 2013 Feb; 50(1):21-5. PubMed ID: 20625912 [TBL] [Abstract][Full Text] [Related]
29. Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial. Eisen A; Cannon CP; Braunwald E; Steen DL; Zhou J; Goodrich EL; Im K; Dalby AJ; Spinar J; Daga S; Lukas MA; O'Donoghue ML J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28077384 [TBL] [Abstract][Full Text] [Related]
30. Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction. Distelmaier K; Schrutka L; Wurm R; Seidl V; Arfsten H; Cho A; Manjunatha S; Perkmann T; Strunk G; Lang IM; Adlbrecht C Atherosclerosis; 2016 Aug; 251():460-466. PubMed ID: 27381657 [TBL] [Abstract][Full Text] [Related]
31. Monocyte to High-Density Lipoprotein Ratio and Contrast-Induced Nephropathy. Karanfil M; Yayla Ç; Ertem AG; Unal S; Açar B Angiology; 2018 Nov; 69(10):917. PubMed ID: 29911398 [No Abstract] [Full Text] [Related]
32. Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events. Sinnaeve PR; Steg PG; Fox KA; Van de Werf F; Montalescot G; Granger CB; Knobel E; Anderson FA; Dabbous OH; Avezum A; Arch Intern Med; 2009 Feb; 169(4):402-9. PubMed ID: 19237725 [TBL] [Abstract][Full Text] [Related]
33. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Lüscher TF; Landmesser U; von Eckardstein A; Fogelman AM Circ Res; 2014 Jan; 114(1):171-82. PubMed ID: 24385510 [TBL] [Abstract][Full Text] [Related]
36. A first-in-man, randomized, placebo-controlled study to evaluate the safety and feasibility of autologous delipidated high-density lipoprotein plasma infusions in patients with acute coronary syndrome. Waksman R; Torguson R; Kent KM; Pichard AD; Suddath WO; Satler LF; Martin BD; Perlman TJ; Maltais JA; Weissman NJ; Fitzgerald PJ; Brewer HB J Am Coll Cardiol; 2010 Jun; 55(24):2727-35. PubMed ID: 20538165 [TBL] [Abstract][Full Text] [Related]
37. Effect of exercise-based cardiac rehabilitation on non-culprit mild coronary plaques in the culprit coronary artery of patients with acute coronary syndrome. Kurose S; Iwasaka J; Tsutsumi H; Yamanaka Y; Shinno H; Fukushima Y; Higurashi K; Imai M; Masuda I; Takeda S; Kawai C; Kimura Y Heart Vessels; 2016 Jun; 31(6):846-54. PubMed ID: 25896129 [TBL] [Abstract][Full Text] [Related]
38. Anticoagulation with the direct thrombin inhibitor argatroban in patients presenting with acute coronary syndromes. Yeh RW; Baron SJ; Healy JL; Pomerantsev E; McNulty IA; Cruz-Gonzalez I; Jang IK Catheter Cardiovasc Interv; 2009 Aug; 74(2):359-64. PubMed ID: 19213062 [TBL] [Abstract][Full Text] [Related]
39. Different clinical and coronary angiographic findings according to ratios of total cholesterol to high-density lipoprotein cholesterol during the acute phase of myocardial infarction. Kosuge M; Kimura K; Ishikawa T; Shimizu T; Sugano T; Sumita S; Hibi K; Takamura T; Toda N; Kanna M; Tsukahara K; Okuda J; Tahara Y; Nozawa N; Furukawa E; Umemura S J Cardiol; 2004 Jun; 43(6):251-8. PubMed ID: 15242074 [TBL] [Abstract][Full Text] [Related]